Skip to main content

Faraday Future Hosts FX Super One Delivery Ceremony for Soccer Legend Andrés Iniesta in Dubai; Middle East Operations Enter Product Delivery and Revenue Phase

Marks the solid execution of FF and FX’s Global Automotive Bridge Strategy in the Middle East, signaling a new phase in the Company’s Middle East Three-Pole strategy and lays a core foundation for future sales. FF and FX will expand Co-Creation initiatives with FX Super One’s first global owner and Developer Co-Creation Officer Andrés Iniesta, accelerating the Middle East’s transition into the new era of EAI-MPV mobility. FX Super One will begin broader deliveries in the UAE, with the goal of becoming the region’s leading MPV.DUBAI, United Arab Emirates, Nov. 27, 2025 (GLOBE NEWSWIRE) — Faraday Future Intelligent Electric Inc. (Nasdaq: FFAI) (“Faraday Future,” “FF,” or “the Company”), a global shared intelligent electric mobility ecosystem company headquartered in California, announced today that the Company hosted a Co-Creation...

Continue reading

InnoCare Announces First Patient Dosed in the Global Phase II Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Prurigo Nodularis

BEIJING, Nov. 27, 2025 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has been dosed in the global Phase II clinical trial of its novel TYK2 inhibitor, Soficitinib (ICP-332), for the treatment of patients with prurigo nodularis in China. Soficitinib is a potent and selective TYK2 inhibitor that is being developed for the treatment of various T-cell related autoimmune disorders. The Current indications under development are strategically positioned within the vast dermatology market, including atopic dermatitis, vitiligo, prurigo nodularis, urticaria, and more. TYK2 plays a key role in the JAK-STAT signaling pathway and is critical in the pathogenesis of inflammatory diseases. Prurigo...

Continue reading

Eisai Submits New Drug Application for Subcutaneous Formulation of “LEQEMBI®” for the Treatment of Early Alzheimer’s Disease in Japan

If approved, lecanemab would be the first and only anti-amyloid treatment in Japan to offer an at-home injection from the initiation of treatment for this progressive, relentless disease TOKYO and CAMBRIDGE, Mass., Nov. 27, 2025 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that Eisai has filed a new drug application for “LEQEMBI®” (brand name, generic name: lecanemab) seeking approval for a subcutaneous formulation (subcutaneous autoinjector: SC-AI) as a new route of administration to Japan’s Pharmaceuticals and Medical Devices Agency (PMDA). The application is based on data from multiple subcutaneous (SC) administration sub-studies of lecanemab conducted...

Continue reading

Optiva Announces Shareholder and Noteholder Approval of Going Private Transaction

TORONTO, Nov. 27, 2025 (GLOBE NEWSWIRE) — Optiva Inc. (TSX: OPT) (“Optiva“) is pleased to announce that the shareholders of Optiva (the “Shareholders“) and the holders (the “Noteholders“) of principal amount of 9.75% senior secured payment-in-kind toggle notes (“PIK Notes“) have approved the proposed plan of arrangement (the “Arrangement“) involving Qvantel Oy (the “Purchaser“) at the special meeting of Shareholders (the “Shareholder Meeting“) and special meeting of Noteholders (the “Noteholder Meeting” and collectively with the Shareholder Meeting, the “Meetings“) held earlier today. Pursuant to the Arrangement, (i) the Purchaser will acquire all of the issued and outstanding common shares of Optiva (the “Shares“)...

Continue reading

South Star Announces Q3 2025 Financial and Operating Results

VANCOUVER, British Columbia, Nov. 27, 2025 (GLOBE NEWSWIRE) — South Star Battery Metals Corp. (“South Star” or the “Company”) (TSXV: STS) (OTCQB: STSBF) is pleased to report its operating and financial results for the quarter ended September 30, 2025 and an additional update on operations. South Star’s Interim Chief Executive Officer, Tiago Cunha, commented, “We are pleased to announce that we have turned a significant corner with the operational issues at the plant. With the successful oversubscribed raise of US$4.8 million, we are now funded to continue the plant upgrades at the Santa Cruz Graphite Mine and on track to restart production in 2026, marking a new chapter of growth and resilience for the Company.” Corporate Highlights During the QuarterAppointments of Tiago Cunha as Interim CEO, Darren Prins as CFO and Corporate...

Continue reading

Abcourt Announces its Results for the First Quarter Ended September 30, 2025 and the Engagement of Red Cloud Securities to Provide Market-Making Services

ROUYN-NORANDA, Quebec, Nov. 27, 2025 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) (OTCQB : ABMBF) announces its results for the first quarter ended September 30, 2025. All monetary values ​in this press release are expressed in Canadian dollars, unless otherwise indicated. Financial statements and management discussion and analysis are available on SEDAR+. Summary of financial results(In dollars) Three months ended September 30  2025   2024  Revenues –   –  Costs of sales 5,009,786   –  Loss from mining operations (5,009,786)   –  Administration expenses 1,416,858   775,757  Care and maintenance 29,288   887,433  Exploration expenses 250,068   501,160  Finance expenses 967,143   136,415  Net loss and comprehensive loss (7,519,605)   (1,839,901)  Net...

Continue reading

Central 1 reports 2025 third quarter financial results

VANCOUVER, British Columbia, Nov. 27, 2025 (GLOBE NEWSWIRE) — Central 1 Credit Union (Central 1) today reported third quarter performance and stable financial results across business lines, consistent with plans and expectations. “This quarter’s results show consistent financial performance and solid management amid economic uncertainty,” said Sheila Vokey, Central 1’s President & CEO. “As an aggregated services provider, we continue to focus time and energy on investing in our payments infrastructure along with the industry and supporting clients through a generational transformation of Canada’s payments system.” Third quarter 2025 compared with third quarter 2024:Net income was $24.9 million, compared with $5.8 million Adjusted net income1 was $25.2 million, compared with $12.5 million Net fair value gains were $30.7 million,...

Continue reading

Patagonia Gold Third Quarter 2025 Financial Results

VANCOUVER, British Columbia, Nov. 27, 2025 (GLOBE NEWSWIRE) — Patagonia Gold Corp. (“Patagonia” or the “Company”) (TSXV: PGDC) announces its financial results for the quarter ended September 30, 2025 (“Q3 2025”). The financial statements together with the related management’s discussion and analysis are available on the Company’s website and under the Company’s profile on SEDAR+ at www.sedarplus.ca. HighlightsGenerated revenue of US$3 million in Q3 2025. Residual production from Cap Oeste yielded 482 gold equivalent ounces(1) produced and sold 707 gold equivalent ounces(1) in Q3 2025.Construction of the Company’s Calcatreu heap leach facility in Rio Negro. As of the end of Q3 2025, the access road, camp, explosives magazine, fuel storage tanks, and power generation plant had been completed. Work on the heap leach pad is well...

Continue reading

Mustang Energy Advances Option with Skyharbour at the 914W Uranium Project and Announces Other Corporate Updates

VANCOUVER, British Columbia, Nov. 27, 2025 (GLOBE NEWSWIRE) — Mustang Energy Corp. (CSE: MEC, OTC:MECPF, FRA:92T) (the “Company” or “Mustang”) is pleased to announce that it has completed the second tranche of milestone payments to Skyharbour Resources Ltd. (“Skyharbour”) under the option agreement between Mustang and Skyharbour dated November 12, 2024 (the “Option Agreement”) regarding the 914W Uranium Project. Pursuant to the Option Agreement, Mustang paid Skyharbour $20,000 in cash, issued 1,098,901 common shares (each, a “Share”) in the capital of Mustang at a deemed price per Share of $0.091, and completed $100,000 in exploration expenditures on the 914W Uranium Project to satisfy the second tranche of milestone payments. The Shares are subject to a customary hold period expiring on the date that is four months and one day...

Continue reading

Western Pacific Trust Company Announces Appointment of Vice-President, Operations

VANCOUVER, British Columbia, Nov. 27, 2025 (GLOBE NEWSWIRE) — Western Pacific Trust Company (“WP”) is pleased to announce the appointment of Catherine Schaeffer, currently serving as Manager, Plan Administration to the role of Vice-President, Operations, effective January 1, 2026, subject to regulatory approval. In this new capacity, Ms. Schaeffer will oversee the operational performance and develop continuous improvement initiatives across the organization. With a proven track record in leadership, operational excellence, and team development, Catherine has been instrumental in driving key projects and strengthening organizational effectiveness in her current role. “We are delighted to welcome Cathy into this expanded leadership role. Her deep operational expertise and commitment to our mission will be invaluable as we continue...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.